ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

11006	Companies
241133	Keywords
169708	Articles
129806	Press releases

Home
Companies
ABIVAX

BRIEF

published on 05/22/2026 at 22:10, 3 months 25 days ago

Abivax unveils its Q1 2026 results and progress on Study 108

Financial Results Treasury Obefazimod RCH Study 108
BRIEF

published on 05/22/2026 at 22:10, 3 months 25 days ago

Abivax Reports Q1 2026 Financials and Key Developments in Obefazimod Trials

Financial Results Abivax Obefazimod Ulcerative Colitis Clinical Trials
PRESS RELEASE

published on 05/22/2026 at 22:05, 3 months 25 days ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Abivax reports Q1 2026 financial results and interim data from UC Study 108, showing strong clinical remission with obefazimod. Cash position at €491.6M. Updates on upcoming trials and financial highlights

Financial Results Abivax Obefazimod Clinical Trials UC Study 108
BRIEF

published on 05/11/2026 at 22:10, 4 months 5 days ago

Abivax: Results of the 2026 Annual General Meeting

Biotechnology Abivax Resolutions General Assembly Immune Response
BRIEF

published on 05/11/2026 at 22:10, 4 months 5 days ago

Abivax Reports Outcomes of Annual General Meeting

Shareholders Abivax Ulcerative Colitis Annual Meeting Resolutions
PRESS RELEASE

published on 05/11/2026 at 22:05, 4 months 5 days ago

Abivax Announces Results of its May 11, 2026 Annual General Meeting
Abivax announces results of its annual general meeting for 2026, including resolutions adopted and details on financial statements and compensation policy

Annual General Meeting Shareholders Financial Statements Biotechnology Abivax
BRIEF

published on 05/05/2026 at 08:05, 4 months 11 days ago

Abivax Reacquires Royalty Certificates and Proceeds with $45M ADS Offering

Abivax Financial Strategy Royalty Certificates ADS Offering Dilution Impact
PRESS RELEASE

published on 05/05/2026 at 08:00, 4 months 11 days ago

Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares
Abivax announces repurchase of royalty certificates and pricing of $45M (€38.5M) offering of American Depositary Shares to strengthen balance sheet and enhance shareholder value

Abivax Repurchase American Depositary Shares Royalty Certificates $45M Offering
BRIEF

published on 04/27/2026 at 18:05, 4 months 19 days ago

ABIVAX: Composition of share capital and voting rights

Euronext Paris Share Capital Voting Rights Abivax Number Of Shares
BRIEF

published on 04/22/2026 at 22:10, 4 months 24 days ago

Abivax unveils key data on obefazimod at Digestive Disease Week

Abivax Obefazimod Ulcerative Colitis Clinical Trials Digestive Disease Week

Accesswire

Published on 09/16/2026 at 23:45, 5 hours 46 minutes ago

Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 8 hours 1 minute ago

Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 12 hours 36 minutes ago

CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 14 hours 31 minutes ago

2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 15 hours 31 minutes ago

Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update

View all ACCESSWIRE

EQS Group

Published on 09/17/2026 at 04:25, 1 hour 6 minutes ago

Zhou Jianjun from Huawei: Building a Grid-Interactive AIDC Solution to Maximize Tokens Per Watt
Published on 09/16/2026 at 23:45, 5 hours 46 minutes ago

WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 6 hours 57 minutes ago

EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 8 hours 16 minutes ago

Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 9 hours 3 minutes ago

EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million

Les Echos

Published on 09/16/2026 at 20:46, 8 hours 45 minutes ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 11 hours 46 minutes ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 11 hours 46 minutes ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 22 hours 31 minutes ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 11 hours ago

Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE